SIGN UP
LOG IN
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga·07/21/2025 12:08:15
Listen to the news
Gainers
- GlucoTrack (NASDAQ:GCTK) shares rose 104.1% to $11.9 during Monday's pre-market session. The company's market cap stands at $3.3 million.
- Helius Medical Tech (NASDAQ:HSDT) shares increased by 86.62% to $16.61. The market value of their outstanding shares is at $6.2 million.
- SAB Biotherapeutics (NASDAQ:SABS) shares rose 46.3% to $3.76. The company's market cap stands at $23.8 million.
- TNF Pharmaceuticals (NASDAQ:TNFA) shares increased by 42.85% to $0.12. The market value of their outstanding shares is at $1.2 million.
- 180 Life Sciences (NASDAQ:ATNF) shares rose 23.94% to $2.33. The company's market cap stands at $11.3 million.
- Autonomix Medical (NASDAQ:AMIX) shares rose 17.08% to $1.85. The market value of their outstanding shares is at $6.3 million.
Losers
- Evotec (NASDAQ:EVO) stock fell 12.7% to $3.72 during Monday's pre-market session. The market value of their outstanding shares is at $1.5 billion.
- Telomir Pharmaceuticals (NASDAQ:TELO) shares decreased by 11.85% to $2.01. The market value of their outstanding shares is at $67.8 million.
- Lisata Therapeutics (NASDAQ:LSTA) shares decreased by 11.07% to $2.25. The company's market cap stands at $21.7 million.
- Bruker (NASDAQ:BRKR) stock fell 7.53% to $37.5. The company's market cap stands at $6.1 billion.
- TransCode Therapeutics (NASDAQ:RNAZ) shares declined by 7.45% to $9.2. The market value of their outstanding shares is at $8.2 million.
- Cyclacel Pharmaceuticals (NASDAQ:CYCC) shares decreased by 7.04% to $12.15. The market value of their outstanding shares is at $20.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.